MyLymphomaTeam

What a stressful time — waiting for biopsy results is genuinely hard, and it makes complete sense to want to know more about what might be ahead. CAR T-cell therapy is a well-established option for relapsed Diffuse Large B-Cell Lymphoma (DLBCL), and many MyLymphomaTeam members have been in a similar position.

Here's a Show Full Answer

What a stressful time — waiting for biopsy results is genuinely hard, and it makes complete sense to want to know more about what might be ahead. CAR T-cell therapy is a well-established option for relapsed Diffuse Large B-Cell Lymphoma (DLBCL), and many MyLymphomaTeam members have been in a similar position.

Here's a general overview of how CAR T-cell therapy works:

- Your own T cells (immune cells) are collected from your blood
- They're sent to a lab where they're genetically modified to recognize and attack lymphoma cells
- A short course of low-dose chemotherapy is given to prepare your body
- The modified cells are then infused back into you through an IV
- Once inside, they seek out and destroy lymphoma cells — and can keep working for weeks or months after There are three FDA-approved CAR T-cell therapies for relapsed or refractory large B-cell lymphoma:

- Axicabtagene ciloleucel (Yescarta)
- Lisocabtagene maraleucel (Breyanzi)
- Tisagenlecleucel (Kymriah)

All three target a marker called CD19, which is commonly found on lymphoma cells. Each differs slightly in how and when they're used, so your oncologist will guide which is most appropriate. Like any treatment, CAR T-cell therapy does carry some risks worth knowing about. Possible side effects include:

- Fever and low blood pressure
- Fatigue and weakness
- Low blood cell counts, raising infection risk
- In some cases, neurological effects like confusion or difficulty speaking (usually temporary with proper care)

Your medical team will monitor you very closely after the infusion, especially in the first few weeks. The encouraging news is that CAR T-cell therapy has shown strong and long-lasting remissions for people with relapsed DLBCL, even when other treatments stopped working. Many MyLymphomaTeam members have shared positive experiences with it as a second-line option.

Hang in there while you wait for biopsy results — one step at a time. 💙

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

6 Treatments for Large B-Cell Lymphoma

CAR T-Cell Therapy for Lymphoma: How Does It Work?